Market Overview:
The global biochips market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for biochips in academic institutes and diagnostic centers for research and development purposes, respectively. Additionally, the growing application of biochips in drug discovery and personalized medicine is also contributing significantly to the growth of this market. On the basis of type, DNA chip held a dominant position in 2017 and is expected to maintain its dominance throughout the forecast period. This can be attributed to their high adoption rate for gene expression profiling, SNP genotyping, methylation analysis, etc., across various end-use applications.
 Industry Outlook.svg)
Product Definition:
Biochips (Microarrays/Microfluidics) are devices that allow for the automated testing of large numbers of biological samples. They can be used to test for the presence or absence of a particular gene, to identify mutations in a gene, or to determine the amount of a particular protein present in a sample. Biochips are important because they allow for rapid and accurate diagnosis of diseases and disorders.
DNA Chip:
DNA chips are used for the detection and analysis of specific gene or protein sequences. It is a high-throughput technique that allows researchers to simultaneously test many samples at once, which has made it an important tool in molecular biology. The technology is relatively new; hence its applications are also limited only by our knowledge and understanding of its potential uses.
Lab-on-a-chip:
A lab-on-a-chip is a device that performs multiple functions in one small space. It can be used for biological or chemical analysis and it helps save time by eliminating the need to run multiple tests on samples. The technology has been around for more than a decade but has only recently started to gain widespread attention due to its potential use in microfluidics and microarrays, two emerging fields of biotechnology/bioinformatics.
Application Insights:
The academic institutes segment dominated the global market in terms of revenue in 2017. This is attributed to rising demand for biochips from various research projects and studies conducted at academic institutes. In addition, growing R&D activities pertaining to microfluidics and lab-on-a-chip technology are further expected to propel product demand over the forecast period.
Diagnostics centers are anticipated to witness lucrative CAGR during the forecast period owing to increasing adoption of advanced diagnostic techniques, such as immunoassays and flow cytometry, which require a large number of biochips per day for diagnosis within a short span of time. Furthermore, an increase in chronic diseases such as cancer is also expected fuel product demand during the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to presence of a large number of players, high adoption rate for advanced technologies, and increasing focus on drug discovery & development. The region is expected to maintain its position during the forecast period owing to continuous innovations and technological advancements in microarray technology.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising investments by governments for developing biochips-based diagnostic products at relatively lower costs as compared with conventional methods used across various countries. In addition, growing awareness about early disease diagnosis coupled with rapidly improving healthcare infrastructure are some factors that can be attributed for rapid increase in demand from Asia Pacific region during the forecast period (2018 - 2030). Moreover, increasing R&D activities relatedto personalized medicineis also expected drive regional growth over next eight years (2030).
Growth Factors:
- Increasing demand for personalized medicine
- Growing prevalence of chronic diseases
- Technological advancements in biochip technology
- Rising investments in life sciences and biotechnology sector
- Growing number of collaborations and partnerships among biochip manufacturers
Scope Of The Report
Report Attributes
Report Details
Report Title
Biochips (Microarrays/Microfluidics) Market Research Report
By Type
DNA Chip, Lab-on-a-chip, Protein Chip
By Application
Academics Institutes, Diagnostics Centers
By Companies
Abbott, Agilent, PerkinElmer, Fluidigm, Illumina, GE Healthcare, Bio-Rad Laboratories, Cepheid, Thermo Fisher, Roche
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Biochips (Microarrays/Microfluidics) Market Report Segments:
The global Biochips (Microarrays/Microfluidics) market is segmented on the basis of:
Types
DNA Chip, Lab-on-a-chip, Protein Chip
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Academics Institutes, Diagnostics Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Agilent
- PerkinElmer
- Fluidigm
- Illumina
- GE Healthcare
- Bio-Rad Laboratories
- Cepheid
- Thermo Fisher
- Roche
 Market Overview.svg)
Highlights of The Biochips (Microarrays/Microfluidics) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- DNA Chip
- Lab-on-a-chip
- Protein Chip
- By Application:
- Academics Institutes
- Diagnostics Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Biochips (Microarrays/Microfluidics) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Biochips are microarrays and microfluidics devices that can be used to detect, identify, and quantify a variety of biological molecules. Biochips can be used for a variety of applications including drug discovery, diagnostics, and environmental monitoring.
Some of the major players in the biochips (microarrays/microfluidics) market are Abbott, Agilent, PerkinElmer, Fluidigm, Illumina, GE Healthcare, Bio-Rad Laboratories, Cepheid, Thermo Fisher, Roche.
The biochips (microarrays/microfluidics) market is expected to grow at a compound annual growth rate of 10.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Biochips (Microarrays/Microfluidics) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Biochips (Microarrays/Microfluidics) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Biochips (Microarrays/Microfluidics) Market - Supply Chain
4.5. Global Biochips (Microarrays/Microfluidics) Market Forecast
4.5.1. Biochips (Microarrays/Microfluidics) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Biochips (Microarrays/Microfluidics) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Biochips (Microarrays/Microfluidics) Market Absolute $ Opportunity
5. Global Biochips (Microarrays/Microfluidics) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Type
5.3.1. DNA Chip
5.3.2. Lab-on-a-chip
5.3.3. Protein Chip
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Biochips (Microarrays/Microfluidics) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Application
6.3.1. Academics Institutes
6.3.2. Diagnostics Centers
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Biochips (Microarrays/Microfluidics) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Biochips (Microarrays/Microfluidics) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Biochips (Microarrays/Microfluidics) Demand Share Forecast, 2019-2029
9. North America Biochips (Microarrays/Microfluidics) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Application
9.4.1. Academics Institutes
9.4.2. Diagnostics Centers
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Type
9.7.1. DNA Chip
9.7.2. Lab-on-a-chip
9.7.3. Protein Chip
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Biochips (Microarrays/Microfluidics) Demand Share Forecast, 2019-2029
10. Latin America Biochips (Microarrays/Microfluidics) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Application
10.4.1. Academics Institutes
10.4.2. Diagnostics Centers
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Type
10.7.1. DNA Chip
10.7.2. Lab-on-a-chip
10.7.3. Protein Chip
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Biochips (Microarrays/Microfluidics) Demand Share Forecast, 2019-2029
11. Europe Biochips (Microarrays/Microfluidics) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Application
11.4.1. Academics Institutes
11.4.2. Diagnostics Centers
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Type
11.7.1. DNA Chip
11.7.2. Lab-on-a-chip
11.7.3. Protein Chip
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Biochips (Microarrays/Microfluidics) Demand Share, 2019-2029
12. Asia Pacific Biochips (Microarrays/Microfluidics) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Application
12.4.1. Academics Institutes
12.4.2. Diagnostics Centers
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Type
12.7.1. DNA Chip
12.7.2. Lab-on-a-chip
12.7.3. Protein Chip
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Biochips (Microarrays/Microfluidics) Demand Share, 2019-2029
13. Middle East & Africa Biochips (Microarrays/Microfluidics) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Application
13.4.1. Academics Institutes
13.4.2. Diagnostics Centers
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Type
13.7.1. DNA Chip
13.7.2. Lab-on-a-chip
13.7.3. Protein Chip
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Biochips (Microarrays/Microfluidics) Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Biochips (Microarrays/Microfluidics) Market: Market Share Analysis
14.2. Biochips (Microarrays/Microfluidics) Distributors and Customers
14.3. Biochips (Microarrays/Microfluidics) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Agilent
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. PerkinElmer
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Fluidigm
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Illumina
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. GE Healthcare
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Bio-Rad Laboratories
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Cepheid
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Thermo Fisher
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Roche
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
